We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+16.88%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.03B
AUM Growth
-$287M
Cap. Flow
-$398M
Cap. Flow %
-38.68%
Top 10 Hldgs %
14.04%
Holding
1,478
New
335
Increased
269
Reduced
346
Closed
503

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$12.3M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$10.9M
3
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10.4M
4
TSLA icon
Tesla
TSLA
+$9.96M
5
NVDA icon
NVIDIA
NVDA
+$8.73M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$10.4M
2
AVGO icon
Broadcom
AVGO
+$9.33M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.68M
4
DESP
Despegar.com
DESP
+$7.15M
5
ORCL icon
Oracle
ORCL
+$6.74M

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Consumer Discretionary 12.74%
3 Healthcare 12.34%
4 Communication Services 10.34%
5 Industrials 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INCY icon
251
Incyte
INCY
$24.4B
$1.03M 0.1%
15,154
+9,102
+150% +$577K
GILD icon
252
Gilead Sciences
GILD
$165B
$1.03M 0.1%
9,264
+6,803
+276% +$724K
FTNT icon
253
Fortinet
FTNT
$117B
$1.03M 0.1%
9,714
-8,861
-48% -$894K
T icon
254
AT&T
T
$163B
$1.03M 0.1%
35,480
-17,746
-33% -$489K
INFA
255
DELISTED
Informatica
INFA
$1.02M 0.1%
+42,036
New +$867K
AKRO
256
DELISTED
Akero Therapeutics
AKRO
$1.02M 0.1%
19,072
-4,918
-21% -$223K
NU icon
257
Nu Holdings
NU
$66.9B
$1.02M 0.1%
74,055
-108
-0.1% -$1.29K
QQQ icon
258
Invesco QQQ Trust
QQQ
$484B
$1.02M 0.1%
1,841
-6,541
-78% -$3.25M
INTU icon
259
Intuit
INTU
$89B
$1M 0.1%
+1,275
New +$863K
CMC icon
260
Commercial Metals
CMC
$8.31B
$1M 0.1%
20,495
+6,820
+50% +$316K
SMA
261
SmartStop Self Storage REIT
SMA
$1.9B
$1,000K 0.1%
+27,600
New +$973K
SSBK
262
DELISTED
Southern States Bancshares
SSBK
$997K 0.1%
+27,408
New +$939K
NCLH icon
263
Norwegian Cruise Line
NCLH
$8.84B
$990K 0.1%
48,817
-7,702
-14% -$138K
FULC icon
264
Fulcrum Therapeutics
FULC
$297M
$985K 0.1%
143,129
-49,078
-26% -$263K
PANW icon
265
Palo Alto Networks
PANW
$297B
$973K 0.09%
4,756
-2,628
-36% -$488K
AGI icon
266
Alamos Gold
AGI
$13.9B
$970K 0.09%
36,510
-6,877
-16% -$184K
RPRX icon
267
Royalty Pharma
RPRX
$25.3B
$966K 0.09%
26,812
+971
+4% +$32.2K
GMS
268
DELISTED
GMS Inc
GMS
$965K 0.09%
+8,875
New +$687K
IRON icon
269
Disc Medicine
IRON
$2.97B
$962K 0.09%
18,156
-44
-0.2% -$2.07K
EXAS
270
DELISTED
Exact Sciences
EXAS
$958K 0.09%
+18,025
New +$916K
CCJ icon
271
Cameco
CCJ
$42.4B
$957K 0.09%
+12,899
New +$688K
PBI icon
272
Pitney Bowes
PBI
$2.39B
$956K 0.09%
87,666
+7,208
+9% +$67.8K
P
273
Everpure Inc
P
$29.9B
$956K 0.09%
16,603
-1,511
-8% -$75.2K
UHS icon
274
Universal Health Services
UHS
$10.5B
$951K 0.09%
5,252
+3,839
+272% +$693K
GENI icon
275
Genius Sports
GENI
$2.11B
$950K 0.09%
91,348
-34,814
-28% -$348K
9 10
11
12 13

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Prelude Capital Management held 1,478 positions worth $1.03B, down 22% from $1.32B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management withdrew a net $398M in Q2 2025, closing 503 positions and reducing 346 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $10.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Alphabet (Google) Class C worth $11.7M.

  • Prelude Capital Management's largest Q2 2025 buy was Alphabet (Google) Class C: 65,723 shares worth $11.7M.
  • Prelude Capital Management added most to Meta Platforms (Facebook) in Q2 2025, an estimated $12.3M increase.
  • Prelude Capital Management's biggest Q2 2025 reduction was Broadcom, cutting an estimated $9.33M.
  • Prelude Capital Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $10.4M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.03B portfolio in Q2 2025.
  • Prelude Capital Management opened 335 new positions and closed 503 in Q2 2025.
  • Prelude Capital Management's portfolio value fell 22% quarter-over-quarter to $1.03B.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.